Abstract

Background: The incidence of second malignancies is markedly increased following transplantation of solid organs. However, the development of Hodgkin's disease has been described relatively infrequently in this setting, and there is little clinical information on these patients and few details on management. Patients and methods: We have reviewed the pathologic specimens and clinical history of four patients who developed Hodgkin's disease following transplantation of solid organs. Results: Hodgkin's disease appeared 26-68 months following transplantation of the kidney (2 cases), liver, and heart. Three cases demonstrated evidence of Epstein-Barr virus (EBV) in Reed-Sternberg cells. One case appears to have arisen after a previous EBV-driven polymorphous lymphoproliferation. Hodgkin's disease was localized in three cases and disseminated in one. All patients achieved remission with standard therapy and continue in remission between 9 and 61 months after therapy. Graft function was preserved in all patients. Conclusion: Hodgkin's disease occurring in the post-transplantation period should probably be treated like Hodgkin's disease in non-immunosuppressed patients. Prolonged disease-free survival is possible and function of the transplanted organ can be preserved.

Original languageEnglish (US)
Pages (from-to)265-270
Number of pages6
JournalAnnals of Oncology
Volume7
Issue number3
DOIs
StatePublished - Mar 1996

Fingerprint

Organ Transplantation
Hodgkin Disease
Human Herpesvirus 4
Reed-Sternberg Cells
Second Primary Neoplasms
Kidney Transplantation
Disease-Free Survival
Transplantation
Transplants
Liver
Incidence
Therapeutics

Keywords

  • Epstein-Barr virus
  • Hodgkin's disease
  • Organ transplantation

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this

Hodgkin's disease following solid organ transplantation. / Bierman, Philip Jay; Vose, Julie Marie; Langnas, Alan Norman; Rifkin, R. M.; Hauke, R. J.; Smir, B. N.; Greiner, Timothy Charles.

In: Annals of Oncology, Vol. 7, No. 3, 03.1996, p. 265-270.

Research output: Contribution to journalArticle

@article{7a4acd8b794342749363faf0deda3756,
title = "Hodgkin's disease following solid organ transplantation",
abstract = "Background: The incidence of second malignancies is markedly increased following transplantation of solid organs. However, the development of Hodgkin's disease has been described relatively infrequently in this setting, and there is little clinical information on these patients and few details on management. Patients and methods: We have reviewed the pathologic specimens and clinical history of four patients who developed Hodgkin's disease following transplantation of solid organs. Results: Hodgkin's disease appeared 26-68 months following transplantation of the kidney (2 cases), liver, and heart. Three cases demonstrated evidence of Epstein-Barr virus (EBV) in Reed-Sternberg cells. One case appears to have arisen after a previous EBV-driven polymorphous lymphoproliferation. Hodgkin's disease was localized in three cases and disseminated in one. All patients achieved remission with standard therapy and continue in remission between 9 and 61 months after therapy. Graft function was preserved in all patients. Conclusion: Hodgkin's disease occurring in the post-transplantation period should probably be treated like Hodgkin's disease in non-immunosuppressed patients. Prolonged disease-free survival is possible and function of the transplanted organ can be preserved.",
keywords = "Epstein-Barr virus, Hodgkin's disease, Organ transplantation",
author = "Bierman, {Philip Jay} and Vose, {Julie Marie} and Langnas, {Alan Norman} and Rifkin, {R. M.} and Hauke, {R. J.} and Smir, {B. N.} and Greiner, {Timothy Charles}",
year = "1996",
month = "3",
doi = "10.1093/oxfordjournals.annonc.a010570",
language = "English (US)",
volume = "7",
pages = "265--270",
journal = "Annals of Oncology",
issn = "0923-7534",
publisher = "Oxford University Press",
number = "3",

}

TY - JOUR

T1 - Hodgkin's disease following solid organ transplantation

AU - Bierman, Philip Jay

AU - Vose, Julie Marie

AU - Langnas, Alan Norman

AU - Rifkin, R. M.

AU - Hauke, R. J.

AU - Smir, B. N.

AU - Greiner, Timothy Charles

PY - 1996/3

Y1 - 1996/3

N2 - Background: The incidence of second malignancies is markedly increased following transplantation of solid organs. However, the development of Hodgkin's disease has been described relatively infrequently in this setting, and there is little clinical information on these patients and few details on management. Patients and methods: We have reviewed the pathologic specimens and clinical history of four patients who developed Hodgkin's disease following transplantation of solid organs. Results: Hodgkin's disease appeared 26-68 months following transplantation of the kidney (2 cases), liver, and heart. Three cases demonstrated evidence of Epstein-Barr virus (EBV) in Reed-Sternberg cells. One case appears to have arisen after a previous EBV-driven polymorphous lymphoproliferation. Hodgkin's disease was localized in three cases and disseminated in one. All patients achieved remission with standard therapy and continue in remission between 9 and 61 months after therapy. Graft function was preserved in all patients. Conclusion: Hodgkin's disease occurring in the post-transplantation period should probably be treated like Hodgkin's disease in non-immunosuppressed patients. Prolonged disease-free survival is possible and function of the transplanted organ can be preserved.

AB - Background: The incidence of second malignancies is markedly increased following transplantation of solid organs. However, the development of Hodgkin's disease has been described relatively infrequently in this setting, and there is little clinical information on these patients and few details on management. Patients and methods: We have reviewed the pathologic specimens and clinical history of four patients who developed Hodgkin's disease following transplantation of solid organs. Results: Hodgkin's disease appeared 26-68 months following transplantation of the kidney (2 cases), liver, and heart. Three cases demonstrated evidence of Epstein-Barr virus (EBV) in Reed-Sternberg cells. One case appears to have arisen after a previous EBV-driven polymorphous lymphoproliferation. Hodgkin's disease was localized in three cases and disseminated in one. All patients achieved remission with standard therapy and continue in remission between 9 and 61 months after therapy. Graft function was preserved in all patients. Conclusion: Hodgkin's disease occurring in the post-transplantation period should probably be treated like Hodgkin's disease in non-immunosuppressed patients. Prolonged disease-free survival is possible and function of the transplanted organ can be preserved.

KW - Epstein-Barr virus

KW - Hodgkin's disease

KW - Organ transplantation

UR - http://www.scopus.com/inward/record.url?scp=0029981777&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029981777&partnerID=8YFLogxK

U2 - 10.1093/oxfordjournals.annonc.a010570

DO - 10.1093/oxfordjournals.annonc.a010570

M3 - Article

C2 - 8740790

AN - SCOPUS:0029981777

VL - 7

SP - 265

EP - 270

JO - Annals of Oncology

JF - Annals of Oncology

SN - 0923-7534

IS - 3

ER -